Venock Inc

Venock is MedTech startup with headquarters in New York City and operations in Munich, Germany. The company is specializing in vascular closure of very large bore access sites (>8 mm) from interventional cardiovascular therapies. Primarily, at this juncture, Venock is focusing on large bore VENOUS closure. Both because this is a currently unmet need in the industry with a >$2B market, and because this is a much more straightforward path to commercialization in terms of regulatory clinical studies. However, we are designing our device so that it does close large bore access sites in BOTH veins and arteries. The current method of closing such access sites is manual compression, which is time consuming, costly, and results in considerable amount of patient discomfort. The Venock system will attain full closure in 1 minute.